FDA
Desvenlafaxine Succinate
The FDA lists this product in 30 strengths and forms.
Composition
- Active ingredients
- DESVENLAFAXINE SUCCINATE EQ 50MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DESVENLAFAXINE SUCCINATE EQ 100MG BASE · Tablet, extended releaseANDA204020-002 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 25MG BASE · Tablet, extended releaseANDA204020-003 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 50MG BASE · Tablet, extended releaseANDA204020-001 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 100MG BASE · Tablet, extended releaseANDA204028-002 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 25MG BASE · Tablet, extended releaseANDA204028-003 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 50MG BASE · Tablet, extended releaseANDA204028-001 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 100MG BASE · Tablet, extended releaseANDA204805-002 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 50MG BASE · Tablet, extended releaseANDA204805-001 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 50MG BASE · Tablet, extended releaseANDA211427-001 · Prescription
- DESVENLAFAXINE SUCCINATE EQ 100MG BASE · Tablet, extended release
At a glance
- Brand name
- Desvenlafaxine Succinate
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Pharmobedient
- Status
- Discontinued
- FDA approval
- 29 Jun 2015
- Application
- ANDA204095-001